Showing results (421-430 of 583) with videos related to
Sort By:
Pageof 59
Genes, Chromosomes & Cancer|May 17, 2024
Superficial fibromas with CTNNB1 mutationAnna Kuntze, R R Meliß, L Ermert, et al.European Journal of Medicinal Chemistry|December 3, 2014
Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4'-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11β-hydroxylaseAngela Stefanachi, Nina Hanke, Leonardo Pisani, et al.BMC Health Services Research|August 21, 2021
Organizational readiness to change as a leverage point for improving safety: a national nursing home surveyEmma D Quach, Lewis E Kazis, Shibei Zhao, et al.Bioorganic & Medicinal Chemistry Letters|March 26, 1999
New selective nonsteroidal aromatase inhibitors: synthesis and inhibitory activity of 2,3 or 5-(alpha-azolylbenzyl)-1H-indolesM Le Borgne, P Marchand, B Delevoye-Seiller, et al.European Journal of Medicinal Chemistry|December 6, 2017
Accelerated skin wound healing by selective 11β-Hydroxylase (CYP11B1) inhibitorsJuliette Emmerich, Chris J van Koppen, Jens L Burkhart, et al.American Journal of Surgery|March 10, 2009
How does patient safety culture in the operating room and post-anesthesia care unit compare to the rest of the hospital?Haytham M A Kaafarani, Kamal M F Itani, Amy K Rosen, et al.Journal of the American Medical Directors Association|July 24, 2020
Safety Climate Associated With Adverse Events in Nursing Homes: A National VA StudyEmma D Quach, Lewis E Kazis, Shibei Zhao, et al.Journal of Medicinal Chemistry|February 24, 2011
Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyaseAngela Stefanachi, Angelo D Favia, Orazio Nicolotti, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|January 25, 2005
2- and 3-[(aryl)(azolyl)methyl]indoles as potential non-steroidal aromatase inhibitorsMarie-Pierre Lézé, Marc Le Borgne, Pascal Marchand, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 21, 2004
Vinorelbine alternating oral and intravenous plus carboplatin in advanced non-small-cell lung cancer: results of a multicentre phase II studyM E R O'Brien, A Szczesna, H Karnicka, et al.Pageof 59